Lesion Assessment and Interventional Heart Failure

By Jozef Bartunek, MD, and Andrew Sharp, MD

The Role of Coronary CT in Determining Lesion-Specific Ischemia and Coronary Plaque Vulnerability

What are the current data and applications?

By Venkat S. Manubolu, MD, MPH, and Matthew J. Budoff, MD

Update on Near-Infrared Spectroscopy/Intravascular Ultrasound

The fundamental aspects and current clinical roles.

By Selcuk Kucukseymen, MD; Francesca Ciatti, MD; Niccolò Ciardetti, MD; Alessio Mattesini, MD; and Carlo Di Mario, MD, PhD

An Update on Coronary Physiology

Pressure wire–based assessment of epicardial stenosis and the integration of multimodal assessment to assess the prognostic implications of epicardial coronary plaque.

By Nicola Ryan, MB, BCh, BAO, MPH

Implantable Sensors for Hemodynamic Monitoring

An updated overview on the currently available technologies and their mechanism of action, advantages and pitfalls, and supporting clinical evidence.

By Simone Fezzi, MD; Mattia Lunardi, MD, MSc; and Faisal Sharif, MD, PhD

Neuromodulation in Heart Failure: Proven and Emerging Solutions

A summary of the pathophysiologic rationale and latest clinical evidence for the role of interventional neuromodulating therapies in treating heart failure.

By Felix Götzinger, MD; Lucas Lauder, MD; and Felix Mahfoud, MD, MA

Pandemic Exacerbates Already-Challenging Cath Lab Staffing

Reviewing the current state of cardiology services across the country, the effects of staffing constrictions, and what programs can do about it.

By Joel Sauer, MBA

An Interview With J. Dawn Abbott, MD, FACC, FSCAI

Dr. Abbott shares her leadership goals and values, insights into the National Cardiovascular Data Registry CathPCI registry, research needs for PCI, and more.